Obalon Therapeutics, Inc.
OBLN · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $4 | $14 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $3 |
| Receivables | $1 | $3 | $0 | $1 |
| Inventory | $2 | $0 | $2 | $2 |
| Other Curr. Assets | $0 | $1 | $2 | $2 |
| Total Curr. Assets | $5 | $8 | $18 | $29 |
| Property Plant & Equip (Net) | $0 | $1 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $0 | $3 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5 | $11 | $20 | $30 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $10 | $0 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | -$5 | $3 | $6 |
| Total Curr. Liab. | $5 | $5 | $4 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $0 |
| Total NC Liab. | $0 | $1 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $6 | $5 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$643 | -$185 | -$172 | -$149 |
| AOCI | -$0 | $0 | -$2 | -$2 |
| Other Equity | $643 | $189 | $191 | $164 |
| Total Equity | -$0 | $5 | $16 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $11 | $20 | $30 |
| Net Debt | $0 | $6 | -$14 | -$11 |